The role of microglia in AD pathogenesis and treatment

Timothy Seabrook, PhD
Brigham and Women's Hospital (Boston, MA)

Mentors

Cynthia Lemere, Ph.D.
Harvard Medical School
Brigham and Women's Hospital
Year Awarded:
2004
Grant Duration:
April 1, 2004 to March 31, 2006
Disease:
Alzheimer's Disease
Award Amount:
$99,892
Grant Reference ID:
A2004274
Award Type:
Standard
Award Region:
US Northeastern

The role of microglia in AD pathogenesis and treatment

Details


One of the hallmarks of Alzheimer's disease (AD) is the accumulation of a protein called beta-amyloid (Aß) in the brain. This protein is formed throughout life, but as some individuals age, the protein begins to accumulate in aggregates called plaques. Surrounding the Aß plaques in the brain is an area of inflammation that involves the immune cells of the brain, called the microglia. Microglia produce both noxious substances that can increase the damage to the brain caused by Aß and helpful substances that help brain cells maintain normal function. Dr. Seabrook is studying the effects of suppressing microglia on the formation of plaques in mice that have been engineered to produce an abnormal human form of Aß in their brain. These experiments will help elucidate the basic role of microglia in the formation of Aß. The role of microglia during vaccination will also be examined, which could lead to a better understanding of their role in this promising therapeutic area.

Publications

Seabrook, T.J., Jiang, L., Maier, M., and Lemere, C.A. (2006) Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice. Glia. 53(7):776-82.  

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.